Publication, Part of Cancer Survival in England
Cancer survival: Index for sub-Integrated Care Boards, 2005 to 2020
National statistics, Accredited official statistics
Geographic variations in cancer survival for colorectal, lung and female breast cancers: 2005 to 2020
Estimates of 1-year net survival for colorectal, lung and female breast cancers are presented in this section. All net survival estimates are age-standardised, colorectal and lung cancer are further standardised for gender.
Lung cancer net survival in England showed the most improvement from 2005 to 2020, with net survival estimates increasing by 19.2 percentage points. There was a 4.0 percentage point increase for colorectal cancer and a 2.6 percentage point increase for female breast cancer net survival estimates during this time.
For 2020, net survival estimates for female breast cancer showed less variation between sub-ICBs than for colorectal and lung cancer. Compared with 2005, the range in net survival estimates between sub-ICBs has decreased for female breast cancer (from a range of 11.7 percentage points in 2005 to 5.4 percentage points in 2020), colorectal cancer (from 13.7 percentage points in 2005 to 13.1 percentage points in 2020) but increased for lung cancer (from 13.0 percentage points in 2005 to 18.7 percentage points in 2020).
Differences in cancer survival between sub-ICBs may be partially related to differences in the proportion of patients diagnosed at an early stage. Earlier diagnosis, that is, when cancers are diagnosed at stages 1 and 2 as opposed to stages 3 and 4, is typically associated with better prognosis. More detail on survival rates by stage can be found in the Cancer Survival in England publication.
Last edited: 13 April 2023 9:31 am